NDC 42023-219

Vasostrict

Vasopressin

Vasostrict is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Vasopressin, Unspecified.

Product ID42023-219_3e046f3c-d3eb-435d-82f9-b650c7540797
NDC42023-219
Product TypeHuman Prescription Drug
Proprietary NameVasostrict
Generic NameVasopressin
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-10-15
Marketing CategoryNDA /
Application NumberNDA204485
Labeler NamePar Pharmaceutical, Inc.
Substance NameVASOPRESSIN, UNSPECIFIED
Active Ingredient Strength40 [USP'U]/100mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 42023-219-10

10 VIAL in 1 CARTON (42023-219-10) > 100 mL in 1 VIAL (42023-219-01)
Marketing Start Date2020-10-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Vasostrict" or generic name "Vasopressin"

NDCBrand NameGeneric Name
42023-164VasostrictVasopressin
42023-190VasostrictVasopressin
42023-219VasostrictVasopressin
42023-220VasostrictVasopressin
71872-7014VasostrictVasopressin
51662-1314VASOPRESSINVASOPRESSIN
52584-302VASOPRESSINvasopressin
63323-302VasopressinVASOPRESSIN

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.